Quick Heal Technologies Allots 32,205 Equity Shares Under ESOP Scheme 2021

1 min read     Updated on 05 Nov 2025, 08:30 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Quick Heal Technologies Limited has allotted 32,205 equity shares under its Employee Stock Option Plan (ESOP) Scheme 2021. The shares have a face value of ₹10.00 each and were issued on November 5, 2025. This allotment increases the company's total issued shares to 5,41,90,467, with a total share capital of ₹54,19,04,670.00. The newly allotted shares will initially be credited under a temporary ISIN before being transferred to the company's permanent ISIN upon final trading approval.

23900418

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited , a prominent player in the cybersecurity sector, has announced the allotment of 32,205 equity shares under its Employee Stock Option Plan (ESOP) Scheme 2021. This move is part of the company's strategy to incentivize and retain talent.

Key Details of the Allotment

Particulars Details
Number of Shares Allotted 32,205
Face Value per Share ₹10.00
Date of Issue November 5, 2025
Distinctive Numbers 7,21,61,177 to 7,21,93,381
Temporary ISIN IN8306L01019
Permanent ISIN INE306L01010
Exercise Price per Share ₹10.00, ₹114.00, ₹119.00, ₹140.00, ₹142.16, ₹176.00, ₹220.00, ₹243.00, ₹291.00

Impact on Share Capital

Following this allotment, Quick Heal Technologies' total issued shares have increased to 5,41,90,467 equity shares. The company's total issued share capital now stands at ₹54,19,04,670.00, divided into 5,41,90,467 equity shares of ₹10.00 each.

Trading and ISIN Details

The newly allotted shares will initially be credited under a temporary ISIN IN8306L01019. Once the final trading approval is received, these shares will be transferred to the company's permanent ISIN INE306L01010. The company has confirmed that these new shares are identical in all respects to the existing equity shares.

ESOP Scheme and Corporate Strategy

The allotment under the ESOP Scheme 2021 underscores Quick Heal's commitment to aligning employee interests with those of the company and its shareholders. Such schemes are often implemented to motivate employees, foster a sense of ownership, and contribute to long-term value creation.

This corporate action reflects Quick Heal Technologies' focus on employee retention and motivation, which can be crucial in the competitive cybersecurity industry where talent is a key differentiator.

Investors and market participants will be keeping a close eye on how this equity dilution might impact the company's stock performance and whether it translates into enhanced employee productivity and company growth in the long run.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.11%+0.20%+1.97%+16.84%-47.03%+96.51%
Quick Heal Technologies
View in Depthredirect
like15
dislike

Quick Heal Technologies Reports Strong Q2 FY26 Recovery with 13.6% Revenue Growth

2 min read     Updated on 15 Oct 2025, 11:03 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Quick Heal Technologies Limited announced robust Q2 FY26 financial results, with revenue increasing 13.6% YoY to ₹83.50 crores. EBITDA surged 200.7% to ₹9.20 crores, while PAT grew 90.6% to ₹7.90 crores. The enterprise segment revenue rose 30% YoY to ₹36.90 crores, and consumer segment revenue increased 8.3% to ₹59.50 crores. The company onboarded its first enterprise customer for the Seqrite Data Privacy Management Platform and signed an MOU with BHASHINI for AI-powered cybersecurity solutions. Quick Heal continues to expand internationally and received industry recognition for its cybersecurity services.

22095212

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited , a leading global cybersecurity solutions provider, has announced its financial results for the second quarter of fiscal year 2026, showcasing a robust recovery and growth across its business segments.

Financial Highlights

The company reported a significant improvement in its financial performance for Q2 FY26:

Metric Q2 FY26 Q2 FY25 YoY Change
Revenue ₹83.50 crores ₹73.50 crores 13.6% ↑
EBITDA ₹9.20 crores ₹3.10 crores 200.7% ↑
EBITDA Margin 11.1% 4.2% 690 bps ↑
PAT ₹7.90 crores ₹4.20 crores 90.6% ↑
PAT Margin 9.5% 5.7% 380 bps ↑

Segment Performance

Quick Heal's performance was driven by growth in both its enterprise and consumer segments:

  • Enterprise Revenue: ₹36.90 crores, up 30% year-over-year
  • Consumer Revenue: ₹59.50 crores, up 8.3% year-over-year

Key Developments

  1. Data Privacy Management Platform: Quick Heal onboarded its first enterprise customer for the Seqrite Data Privacy Management Platform, which aids enterprises in achieving and maintaining compliance with privacy laws like the DPDP Act.

  2. AI-Powered Cybersecurity: The company signed an MOU with BHASHINI to integrate Seqrite's AI-powered cybersecurity modules into India's multilingual AI platform, offering data privacy solutions in 22 languages.

  3. International Expansion: Quick Heal continues to see growth in international revenue, driven by new market entries in Southeast Asia and the Middle East.

  4. Awards and Recognition: Seqrite received the "Cybersecurity Service Provider of the Year" Award at the Times Secure India Summit 2025, while Quick Heal won "The Leading Cybersecurity Solutions Brand of 2025" at NCN Excellence Awards.

Management Commentary

Dr. Kailash Katkar, Chairman and Managing Director of Quick Heal Technologies Limited, commented on the results: "Q2 FY26 witnessed good performance across both verticals of our business, which is a clear reflection of the resilience and diversification of our cybersecurity portfolio through continued investments in differentiated, AI-led innovations. The consumer business has shown recovery with seasonal tailwinds, while our enterprise vertical continues to gain momentum through innovative solution offerings."

Ankit Maheshwari, Chief Financial Officer, added: "We are pleased with the revenue growth momentum this quarter. Owing to the stable cost structures, the revenue improvement enabled us to restore healthy margins. Our continued investments in R&D and S&M for market expansion are key tenets for our long-term pivot and have started to show positive traction."

Future Outlook

As Quick Heal Technologies moves into the second half of the fiscal year, the company remains focused on scaling its AI-led innovations, expanding partner ecosystems, and driving predictable growth. With a healthy order pipeline and a diversified revenue mix, Quick Heal is well-positioned to deliver sustainable shareholder value in the evolving cybersecurity landscape.

The company's strategic focus on both consumer and enterprise segments, coupled with its expansion into international markets and investment in cutting-edge technologies like AI, positions it strongly for continued growth in the global cybersecurity market.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.11%+0.20%+1.97%+16.84%-47.03%+96.51%
Quick Heal Technologies
View in Depthredirect
like16
dislike
More News on Quick Heal Technologies
Explore Other Articles
318.45
-6.85
(-2.11%)